Various graft vs. host diseases (GvHD) in rodents can be prevented and treated by malononitrilamides (MNAs)

被引：0
|
作者：
H. U. Schorlemmer
R. Kurrle
R. R. Bartlett
机构：
[1] Research Laboratories Hoechst Marion Roussell (HMR),
[2] TA Rheumatology/Immunology,undefined
[3] c/o Behringwerke AG,undefined
[4] P.O. Box 1140,undefined
[5] D-35001 Marburg,undefined
[6] Germany,undefined
[7] Fax +49 6421 39 46 63,undefined
[8] Werk Kalle-Albert,undefined
[9] D-65174 Wiesbaden,undefined
[10] Germany,undefined
来源：
Inflammation Research | 1997年 / 46卷 / Suppl 2期
关键词：
Host Disease;
D O I：
10.1007/s000110050160
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：165 / 166
页数：1
相关论文
共 50 条
  • [31] Ocular graft vs. host disease experience from MD Anderson Cancer Center: Newly described clinical spectrum and new approach to the management of stage III and IV ocular GVHD
    Kim, SK
    Couriel, D
    Ghosh, S
    Champlin, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 49 - 50
  • [32] IL-15 serves as a co-stimulator in determining the activity of autoreactive CD8 T cells in an experimental mouse model of graft vs. host disease (GvHD)
    Miyagawa, F.
    Tagaya, Y.
    Waldmann, T. A.
    Katz, S. I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S117 - S117
  • [33] Implications of donor lymphocyte infusion (DLI) on acute graft versus host disease (GVHD) tolerance in patients in relapse vs. remission post matched allogeneic bone marrow transplantation (BMT).
    Nagler, A
    Ackerstein, A
    Naparstek, E
    Or, R
    Kapelushnik, J
    Samuel, S
    Slavin, S
    BLOOD, 1997, 90 (10) : 4470 - 4470
  • [34] A Bayesian, Phase II Randomized Trial of Extracorporeal Photopheresis (ECP) Plus Steroids Versus Steroids-Alone in Patients with Newly Diagnosed Acute Graft Vs. Host Disease (GVHD): The Addition of ECP Improves Gvhd Response and the Ability to Taper Steroids
    Alousi, Amin M.
    Bassett, Roland
    Chen, Julianne
    Overman, Bethany J.
    Hosing, Chitra M.
    Popat, Uday R.
    Shpall, Elizabeth J.
    Nieto, Yago
    Qazilbash, Muzaffar H.
    Khouri, Issa F.
    Kebriaei, Partow
    Ahmed, Sairah
    Shah, Nina
    Rezvani, Katayoun
    Kondo, Kayo
    Ciurea, Stefan O.
    Hymes, Sharon R.
    Neumann, Joyce L.
    Molldrem, Jeffrey J.
    Plair, Tamera R.
    Champlin, Richard E.
    BLOOD, 2015, 126 (23)
  • [35] Clinical and laboratory features of minor ABO incompatible reduced intensity blood hematopoietic cell transplantation using cyclosporin (CsA) vs. CsA/mycophenolate mofetil (CsA/MMF) for graft-vs-host disease (GVHD) prophylaxis.
    Reese, A
    Stevens, WT
    Donohue, T
    Chakrabarti, S
    Wesley, R
    Castro, K
    Fowler, D
    Bishop, MR
    Stroncek, D
    Leitman, S
    Childs, RW
    Bolan, CD
    BLOOD, 2003, 102 (11) : 708A - 708A
  • [36] A Dual ICOS/CD28 Antagonist ICOSL Variant Ig Domain (vIgDTM) Potently Suppresses Mouse Collagen-Induced Arthritis and Human Xenograft Graft Vs. Host Disease (GvHD)
    Dillon, Stacey
    Lewis, Katherine
    Swanson, Ryan
    Evans, Lawrence
    Kornacker, Michael
    Levin, Steve
    Wolfson, Martin
    Rickel, Erika
    Bort, Susan
    Mudri, Sherri
    Moss, Aaron
    Seaberg, Michelle
    Bhandari, Janhavi
    MacNeil, Sean
    Hoover, Joe
    Rixon, Mark
    Peng, Stanford
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [37] Use of peripheral blood stem cells (PBSC) is likely to be associated with higher incidence of lung involvement in chronic graft vs. host disease (GVHD) following allogeneic hematopoetic stem cell transplant (AHSCT).
    Kulkarni, S
    Powles, R
    Sirohi, B
    Treleaven, J
    Singhal, S
    Saso, R
    Rudin, C
    Horton, C
    Mehta, J
    BLOOD, 2001, 98 (11) : 397A - 397A
  • [38] Use of peripheral blood stem cells (PBSC) is likely to be associated with higher incidence of lung involvement in chronic graft vs. host disease (GVHD) following allogeneic hematopoetic stem cell transplant (AHSCT)
    Kulkarni, S
    Powles, R
    Sirohi, B
    Saso, R
    Treleaven, J
    Horton, C
    Singhal, S
    Mehta, J
    BONE MARROW TRANSPLANTATION, 2002, 29 : S173 - S173
  • [39] ACUTE GRAFT VERSUS HOST-DISEASE MORTALITY IN MURINE P VS F1 MODEL CAN BE PREVENTED BY PRETREATMENT OF THE RECIPIENT MICE WITH ANTI ASIALO GM1 ANTIBODY
    VARKILA, K
    HURME, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (01) : 124 - 124
  • [40] Allogeneic hematopoietic chimerism in mice treated with sub-lethal myeloablation and anti-CD154 antibody: Absence of graft vs. host disease (GVHD), induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD mice
    Seung, E
    Iwakoshi, N
    Woda, BA
    Markees, TG
    Mordes, JP
    Rossini, AA
    Greiner, DL
    FASEB JOURNAL, 2000, 14 (06): : A1071 - A1071
12345